[HTML][HTML] Efficacy and safety of gemcitabine plus S-1 vs. gemcitabine plus nab-paclitaxel in treatment-naïve advanced pancreatic ductal adenocarcinoma

Z Zhu, H Tang, J Ying, Y Cheng, X Wang… - Cancer Biology & …, 2023 - ncbi.nlm.nih.gov
Objective: Gemcitabine plus nab-paclitaxel (GnP) is the standard first-line therapy for advanced
pancreatic ductal adenocarcinoma (PDAC). S-1, an oral fluoropyrimidine derivative, as …

The prognostic role of WeChat-based instant doctor–patient communication in patients with advanced pancreatic cancer

H Tang, Z Zhu, J Ying, T You, H Ge, Y Cheng… - Journal of Cancer …, 2023 - Springer
Background Patients with advanced pancreatic ductal adenocarcinoma (PDAC) need timely
medical assistance since the emergence of complications due to the disease and antitumor …

Stability and generalization analysis of gradient methods for shallow neural networks

Y Lei, R Jin, Y Ying - Advances in Neural Information …, 2022 - proceedings.neurips.cc
Ying. Fine-grained analysis of stability and generalization for stochastic gradient descent. In
Ying. Stability and generalization of stochastic gradient methods for minimax problems. In …

Treatment and prognosis of fetal lymphangioma

L Jiao-Ling, W Hai-Ying, Z Wei, L Jin-Rong… - European Journal of …, 2018 - Elsevier
Objective To investigate the treatment and prognosis of fetal lymphangioma and factors that
inform treatment selection. Study design Retrospective analysis of 79 patients with fetal …

[HTML][HTML] A population-based study of synchronous distant metastases and prognosis in patients with PDAC at initial diagnosis

L Zhang, R Jin, X Yang, D Ying - Frontiers in Oncology, 2023 - frontiersin.org
Objective: Cancer of the pancreas is a life-threatening condition and has a high distant
metastasis (DM) rate of over 50% at diagnosis. Therefore, this study aimed to determine whether …

W346 inhibits cell growth, invasion, induces cycle arrest and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway

…, B Weng, Z Wang, Y Kang, L Shi, G Huang, S Ying… - Tumor Biology, 2016 - Springer
The therapeutic agent selectively killing cancer cells is urgently needed for gastric cancer
treatment. Curcumin has been investigated for its effect on the cancer treatment because of its …

Global trends of targeted therapy for hepatocellular carcinoma: A bibliometric and visualized study from 2008 to 2022

XA Yang, R Jin, LM Zhang, DJ Ying - Medicine, 2023 - journals.lww.com
… How to cite this article: Yang XA, Jin R, Zhang LM, Ying DJ. Global trends of targeted
therapy for hepatocellular carcinoma: A bibliometric and visualized study from 2008 to 2022. …

Surveillance and control of post-transmission schistosomiasis in Jiaxing prefecture, Zhejiang province, China

WL Wu, W Jin-Rong, W Li-Yong, H Yu-Ying, X Xiao-Fei… - Acta tropica, 2005 - Elsevier
A surveillance system has been put in place in the Zhejiang province since achieving there
the criteria for transmission interruption of schistosomiasis japonica. Suspected patients and …

Comparison of the new national standard magnitude scales with the traditional magnitude scales

T Lin, Q Guoliang, S Jinrong, H Chunmei, F Ying… - Acta Seismologica …, 2018 - dzxb.org
The new national standard magnitude scales and traditional magnitude scales are analyzed
by using broadband seismic data from Sichuan seismic network science April of 2013. The …

Peptidomimetic suppresses proliferation and invasion of gastric cancer cells by fibroblast growth factor 2 signaling cascade blockage

…, Q Chen, Y Kang, C Xu, L Fan, H Ye, S Ying… - Anti-Cancer …, 2016 - journals.lww.com
Fibroblast growth factor 2 (FGF2) is closely involved in a variety of tumors, including gastric
cancer (GC). FGF2 inhibitors exert good antitumor activity, but no FGF2 inhibitor has been …